{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:23:49Z","timestamp":1787783029936,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P30AR075043"],"award-info":[{"award-number":["1P30AR075043"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR080662"],"award-info":[{"award-number":["R01AR080662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UC2 AR081033"],"award-info":[{"award-number":["UC2 AR081033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01AR072129"],"award-info":[{"award-number":["K01AR072129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaci.2025.08.026","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T08:00:35Z","timestamp":1757491235000},"page":"1588-1599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of disease-specific regulatory networks in prurigo nodularis versus atopic dermatitis through ATAC\/RNA single-nucleus profiling"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8480-2413","authenticated-orcid":false,"given":"Yuntian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Bogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gharaee-Kermani","family":"Mehrnaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison C.","family":"Billi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michelle","family":"Kahlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Julia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-5722","authenticated-orcid":false,"given":"Lam C.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.08.026_bib1","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s13555-022-00782-2","article-title":"Prurigo nodularis: a review of IL-31RA blockade and other potential treatments","volume":"12","author":"Bewley","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2025.08.026_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jid.2024.06.1276","article-title":"Pathophysiology of prurigo nodularis: neuroimmune dysregulation and the role of type 2 inflammation","volume":"145","author":"Kwatra","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.jaci.2025.08.026_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.alit.2022.04.003","article-title":"Peripheral itch sensitization in atopic dermatitis","volume":"71","author":"Tominaga","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.08.026_bib5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2021.10.004","article-title":"Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab","volume":"149","author":"Tsoi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib6","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22\u2013producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17\u2013producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaci.2023.07.005","article-title":"Single-cell profiling of prurigo nodularis demonstrates immune\u2013stromal crosstalk driving profibrotic responses and reversal with nemolizumab","volume":"153","author":"Ma","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib8","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib9","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13\u2013dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/all.13954","article-title":"Interleukin-13: targeting an underestimated cytokine in atopic dermatitis","volume":"75","author":"Bieber","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.08.026_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/medicines7010004","article-title":"Association between prurigo nodularis and etiologies of peripheral neuropathy: suggesting a role for neural dysregulation in pathogenesis","volume":"7","author":"Hughes","year":"2020","journal-title":"Medicines"},{"key":"10.1016\/j.jaci.2025.08.026_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/17512433.2021.1852080","article-title":"Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis","volume":"14","author":"Williams","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jaci.2025.08.026_bib13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jaad.2020.04.182","article-title":"Prurigo nodularis","volume":"83","author":"Williams","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamadermatol.2023.2609","article-title":"Modulation of neuroimmune and epithelial dysregulation in patients with moderate to severe prurigo nodularis treated with nemolizumab","volume":"159","author":"Deng","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.det.2018.02.003","article-title":"Prurigo nodularis and its management","volume":"36","author":"Zeidler","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2025.08.026_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jid.2019.07.713","article-title":"Increased IL-26 expression promotes T helper type 17\u2013 and T helper type 2\u2013associated cytokine production by keratinocytes in atopic dermatitis","volume":"140","author":"Kamijo","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jid.2023.12.018","article-title":"IL-26 potentiates type 2 skin inflammation in the presence of IL-1\u03b2","volume":"144","author":"Bier","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib19","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/s41467-023-39484-4","article-title":"Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis","volume":"14","author":"Fries","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.08.026_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaci.2023.04.019","article-title":"Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis","volume":"152","author":"Alkon","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaci.2021.07.025","article-title":"Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis","volume":"149","author":"Alkon","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib22","article-title":"Single-cell RNA sequencing reveals dysregulated fibroblast subclusters in prurigo nodularis","author":"Patel","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jaci.2025.08.026_bib23","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jid.2023.05.011","article-title":"Transcriptomic landscape of prurigo nodularis lesional skin CD3+ T cells using single-cell RNA sequencing","volume":"143","author":"Calugareanu","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2019.11.047","article-title":"Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses","volume":"145","author":"Tsoi","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis","volume":"145","author":"He","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nmeth.4401","article-title":"ChromVAR: inferring transcription-factor\u2013associated accessibility from single-cell epigenomic data","volume":"14","author":"Schep","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaci.2025.08.026_bib27","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/s41467-021-25960-2","article-title":"Confronting false discoveries in single-cell differential expression","volume":"12","author":"Squair","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.08.026_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","article-title":"Trial of nemolizumab in moderate-to-severe prurigo nodularis","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.08.026_bib29","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"},{"issue":"10451","key":"10.1016\/j.jaci.2025.08.026_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(24)01203-0","article-title":"Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials","volume":"404","author":"Silverberg","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.08.026_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-021-00308-5","article-title":"High heterogeneity undermines generalization of differential expression results in RNA-Seq analysis","volume":"15","author":"Cui","year":"2021","journal-title":"Hum Genomics"},{"issue":"7455","key":"10.1016\/j.jaci.2025.08.026_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature12199","article-title":"BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis","volume":"498","author":"Roychoudhuri","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.08.026_bib33","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jid.2024.02.036","article-title":"Identifying atopic dermatitis risk loci in 1,094,060 individuals with subanalysis of disease severity and onset","volume":"144","author":"Pasanen","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.08.026_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 cells in health and disease","volume":"35","author":"Nakayama","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2025.08.026_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2814510","article-title":"Bach2: a key regulator in Th2-related immune cells and Th2 immune response","volume":"2022","author":"Liu","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2025.08.026_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCRESAHA.115.306341","article-title":"Transcription factor Runx2 promotes aortic fibrosis and stiffness in type 2 diabetes mellitus","volume":"117","author":"Raaz","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jaci.2025.08.026_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.201700482R","article-title":"Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis","volume":"32","author":"M\u00fcmmler","year":"2018","journal-title":"FASEB J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925009431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925009431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:36:00Z","timestamp":1780202160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925009431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0091674925009431"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.08.026","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of disease-specific regulatory networks in prurigo nodularis versus atopic dermatitis through ATAC\/RNA single-nucleus profiling","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}